Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1567)	11/30/2006 11:44:36 AM
From: Jibacoa	Read Replies (2) of 3722

DRRX Had a good up gap today after it announced positive results from a PI on its ORADUR,as reported on Nov. 29 by Pain Therapeutics, which is DRRX's licensee of ORADUR based products. ORADUR was found to be safe and well-tolerated, and its release profile well suited for use in the inteded population, with no unexpected adverse events in the PI.<g> King Pharmaceuticals, will be commercializing the drug candidate, if approved by the FDA. Another ORADUR based oxycodone (Remoxy)is now on PIII The stock traded as high as 5.55 in the first few minutes, & is now trying to close some of the upgap,but still up 28%.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next